Literature DB >> 9762875

Testing the measurement properties of the Short Form-36 Health Survey in a frail elderly population.

K Stadnyk1, J Calder, K Rockwood.   

Abstract

The Short Form-36 Health Survey (SF-36) is a widely used measure of health-related quality of life, however, its suitability for frail older persons is not well documented. This study examines the measurement properties of the SF-36 in a frail older patient population. Patients consecutively admitted to two geriatric services (n = 146) were administered the SF-36 and comparative measures on admission and discharge. Internal consistency (0.75-0.91) and test-retest reliability (0.24-0.80) did not meet standards for clinical application of the tool. Four subscales were moderately correlated with comparative measures (Physical Function 0.53 to -0.76; Bodily Pain -0.61; Vitality -0.58; Mental Health -0.63). The results of effect size, standardized response mean, and relative efficiency statistics were consistent in documenting only minimal change for the SF-36 subscales. The SF-36 appears to be reliable and valid, although its ability to monitor clinical change for frail older patients is questionable.

Entities:  

Mesh:

Year:  1998        PMID: 9762875     DOI: 10.1016/s0895-4356(98)00061-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  37 in total

1.  On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

Authors:  C B Terwee; F W Dekker; W M Wiersinga; M F Prummel; P M M Bossuyt
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

Review 2.  Quality of life in older people: a structured review of generic self-assessed health instruments.

Authors:  K L Haywood; A M Garratt; R Fitzpatrick
Journal:  Qual Life Res       Date:  2005-09       Impact factor: 4.147

3.  Functional status, health problems, age and comorbidity in primary care patients.

Authors:  M Wensing; E Vingerhoets; R Grol
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 4.  Are factor analytical techniques used appropriately in the validation of health status questionnaires? A systematic review on the quality of factor analysis of the SF-36.

Authors:  Henrica C W de Vet; Herman J Adèr; Caroline B Terwee; François Pouwer
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

5.  The link between depressive symptoms, negative cognitive bias and memory complaints in older adults.

Authors:  M K Crane; H R Bogner; G K Brown; J J Gallo
Journal:  Aging Ment Health       Date:  2007-11       Impact factor: 3.658

6.  The challenge of validating SF-12 for its use with community-dwelling elderly in Israel.

Authors:  Netta Bentur; Yaron King
Journal:  Qual Life Res       Date:  2009-12-11       Impact factor: 4.147

7.  Stability of preferences for end-of-life treatment after 3 years of follow-up: the Johns Hopkins Precursors Study.

Authors:  Marsha N Wittink; Knashawn H Morales; Lucy A Meoni; Daniel E Ford; Nae-Yuh Wang; Michael J Klag; Joseph J Gallo
Journal:  Arch Intern Med       Date:  2008-10-27

8.  Patient ethnicity and perceptions of families and friends regarding depression treatment.

Authors:  Hillary Bogner; Larissa N Dobransky; Marsha N Wittink
Journal:  Ethn Health       Date:  2008-11-01       Impact factor: 2.772

9.  A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients.

Authors:  John Sellors; Janusz Kaczorowski; Connie Sellors; Lisa Dolovich; Christel Woodward; Andrew Willan; Ron Goeree; Roxanne Cosby; Kristina Trim; Rolf Sebaldt; Michelle Howard; Linda Hardcastle; Jeff Poston
Journal:  CMAJ       Date:  2003-07-08       Impact factor: 8.262

10.  Walker use, but not falls, is associated with lower physical functioning and health of residents in an assisted-living environment.

Authors:  Daniel A Andersen; Bernard A Roos; Damian C Stanziano; Natasha M Gonzalez; Joseph F Signorile
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.